biosimilar News

New Pharmaceuticals research report from Espicom Business Intelligence is now available from Fast Market Research

The Food & Drug Administration is scheduled to release guidelines for the approval of biosimilars by the end of 2011

Frost & Sullivan hosts complimentary webinar discussing the potential benefits and risks of an untapped market

Biosimilars and FDA talk at 4th Protein Therapeutics Conference Oct 19-21

Frost & Sullivan hosts complimentary webinar: assessing the fluctuations and opportunities in the pharmaceutical and biotechnology industry

New Pharmaceuticals market report from Datamonitor: "Russia Pharmaceutical Market Overview Pharma companies target Russia despite the challenges it presents"

Recently published research from Datamonitor, "Pharmaceutical Key Trends 2011 - Biosimilar Market Overview", is now available at Fast Market Research

New Pharmaceuticals market report from Datamonitor: "Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally"

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

Monoclonal Antibodies in the Pipeline: A Segment of Major Growth Report

New Pharmaceuticals research report from Espicom Business Intelligence is now available from Fast Market Research

New Pharmaceuticals research report from Business Insights is now available from Fast Market Research

Bharatbook added a new report on "Biosimilars : Beyond the first product wave" which gives in-depth analysis and forecast on the Biosomilars market.

Having issued a concept paper on the topic in October 2009, the European Medicines Agency has now confirmed that it is to publish its highly anticipated biosimilar monoclonal antibody development guidance in November 2010.

Bharatbook added a new report on "Global Biopharmaceutical Market Report (2010-2015)" gives a deep insight into the global biopharmaceutical market.

Fast Market Research recommends "The Future of the Generics Industry: Opportunities, threats and key trends" from Business Insights, now available

Drawing on the strength of SMi's successful Generics, Supergenerics and Patent Strategies series, we are proud to present our inaugural Biosimilars & Biobetters conference taking place on the 22nd & 23rd September 2010 in London, UK.

New Pharmaceuticals research report from Datamonitor, "Australia Pharmaceutical Market Overview - Reforms and continued price cuts will change the healthcare landscape", is now available from Fast Market Research

Fast Market Research recommends "UK Pharmaceutical Market Overview - Pricing and reimbursement challenges dampen future growth" from Datamonitor, now available

La Cátedra Curaxys se dedicará al desarrollo de medicamentos biológicos, y a la formación de investigadores y gestores especializados en biotecnología

Recently published report Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 will provide you with information that you need to understand current trends and future possibilities for those drugs.

Fast Market Research recommends "Opportunities in Emerging Pharma Markets: Strategies for optimizing growth in key regions and therapeutic areas" from Business Insights, now available

Bharatbook.com added a new report on " The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways " which provides insights on the biosimilars market revenues and growth until 2015.

The biosimilars market is highly fragmented and its huge opportunities are attracting new players. Favourable regulatory developments in biosimilars sector are expected to increase market share and profit margins while reducing medical expenditure.

As the Federal Trade Commission weighs into the biosimilars debate in the US, new research Biosimilars Series: Forecast Analysis – Beyond the generics horizon by independent market analyst Datamonitor forecasts that the success of the -